SciSparc: Subsidiary NeuroThera Labs’ CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-World Clinical Data on an S&P 500 Company’s Quantum Architecture

Positive

AI Analysis

Summary

SciSparc's subsidiary NeuroThera Labs announced that CliniQuantum achieved a 16.8-fold computational acceleration using GPU-accelerated quantum simulation for analyzing gene combinations with real-world clinical data. This represents a technology advancement for the company's CNS drug development platform.

Outcome Details

CliniQuantum's GPU-accelerated quantum-simulation platform achieved 16.8-fold computational acceleration using 64-core CPU with single NVIDIA T4 Tensor Core GPU compared to CPU-only implementation

Importance:3/10

Sentiment:

0.40

quantum computingdrug discoverycomputational technologyGPU accelerationgene analysis

Related Companies

$SPRC $NTLX

Read the original article

Published by GlobeNewswire Pharma on October 7, 2026 12:22 PM

Read Original